AbbVie, Eli Lilly and Gilead Hit Record Highs as Tech Selloff Reshuffles Money
AbbVie, Eli Lilly and Gilead Sciences shares trade at or near record highs as the tech selloff pushes investors toward pharma as safer bets. The stated driver is rotation, not fundamentals.